Eyeworld Supplements

Program Preview 2021

This is a supplement to EyeWorld Magazine.

Issue link: https://supplements.eyeworld.org/i/1364341

Contents of this Issue

Navigation

Page 16 of 74

2021 ASCRS Annual Meeting Preview Program | 17 8:00–9:00 a.m. Session I: AGS/ASCRS Joint Symposium Patient with Controlled Glaucoma but Visually Significant Cataract: No Problem! • No Glasses: Cataract Surgery with Refractive IOL in Glaucoma Patients • No Medications: Cataract Surgery Combined with MIGS • No Chamber : Cataract Surgery in Patients with Primary Angle Closure Glaucoma • No Zonules: Cataract Surgery in Patients with Pseudoexfoliative Glaucoma • No Pressure: Cataract Surgery in Patients with an Overfiltering Trabeculectomy • New Surgical Technology on the Horizon: Yes! • Panel Discussion and Q&A 9:00–10:10 a.m. Session II: Glaukomtecken Practical Tech For the Modern Ophthalmologist Part 1: Here and Now Tech: Pearls to Using the Tech You Already Have • What THEY See is What You Get: Improving Reliability and Understanding of Visual Field Testing • What YOU See is What You Get: Improving Reliability and Understanding of OCT • What You Get is What You Get: Making Decisions Based on What You Acquire • Panel Discussion and Q&A Part 2: Next Tech • Modernizing Your Visual Field Toolbox: HVF 24-2 C and SITA Faster • TonoTek: Tonometry from I-to-OP • Glaucoma NextTecken • Panel Discussion and Q&A 10:40–11:50 a.m. Session III: Medications and Lasers Practical Concepts for Enhancing Glaucoma Care Part 1: Medications • New Kids on the Block Part 1: New Meds • New Kids on the Block Part 2: New Deliveries • Mix it Up: The Role of Fixed Combination and Compounded Therapies • Panel Discussion and Q&A Part 2: Lasers: Is SLT First Line Therapy? • Pro: LiGHT Trial and Other Evidence • Con: Meds Should Come First • Case Studies • Panel Discussion and Q&A Part 3: The Changing Paradigm for Glaucoma Therapy • Is There a Role for Cycloablation in Early to Moderate Glaucoma? • Up in Smoke: Role of Marijuana in Glaucoma Treatment • Panel Discussion and Q&A 11:50 a.m.–12:05 p.m. Session IV: Keynote Business of Glaucoma 2021 and Beyond 1:05–2:20 p.m. Session V: Surgical Glaucoma Spotlight Part 1 • TM-Based MIGS • Subconjunctival MIGS • When to Consider Conventional Surgery • Panel Discussion and Q&A ASCRS SUBSPECIALTY DAY ASCRS GUCOMA DAY PRELIMINARY PROGRAM

Articles in this issue

Archives of this issue

view archives of Eyeworld Supplements - Program Preview 2021